Clinical Trial Update: Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a prophylactic agent to prevent venous thromboembolism after total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Snippet

Sponsor: Hanyang University Seoul Hospital | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED